As of 2024-12-11, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (61.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -339.2%.
The range of the Relative Valuation is (62.44) - (64.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.4x - 40.8x | 35.0x |
| Forward P/E multiples | 19.9x - 29.3x | 20.6x |
| Fair Price | (62.44) - (64.56) | (61.21) |
| Upside | -344.0% - -352.3% | -339.2% |
| Date | P/E |